Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00179218 · ClinicalTrials.gov registry record · Phase 2

The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

A Phase 2 study of End Stage Renal Disease, sponsored by Vanderbilt University.

Completed
Registry status
Phase 2
Development phase
19
Enrollment target
1
Study location

NCT00179218 is a Phase 2 study of End Stage Renal Disease that has completed, run by Vanderbilt University. The registered enrollment target is 19 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00179218, a Phase 2 study of End Stage Renal Disease, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Phase 2
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.

Conditions Studied

End Stage Renal Disease

Interventions

  • BEHAVIORAL exercise
  • DRUG nutritional supplementation

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2005-04
Est. Completion 2007-01
Phase Phase 2

Sponsor

Vanderbilt University

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00179218

The ClinicalTrials.gov registry entry for NCT00179218 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (98% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which exercise is the first listed.

NCT00179218 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00179218 about?

NCT00179218 is a clinical study titled "The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients". The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.

What is the current status of trial NCT00179218?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2005-04. Estimated completion is 2007-01.

What conditions does trial NCT00179218 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT00179218?

The interventions under investigation include: exercise (BEHAVIORAL), nutritional supplementation (DRUG).

Who is sponsoring clinical trial NCT00179218?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00179218 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.